<code id='A7DC377DEF'></code><style id='A7DC377DEF'></style>
    • <acronym id='A7DC377DEF'></acronym>
      <center id='A7DC377DEF'><center id='A7DC377DEF'><tfoot id='A7DC377DEF'></tfoot></center><abbr id='A7DC377DEF'><dir id='A7DC377DEF'><tfoot id='A7DC377DEF'></tfoot><noframes id='A7DC377DEF'>

    • <optgroup id='A7DC377DEF'><strike id='A7DC377DEF'><sup id='A7DC377DEF'></sup></strike><code id='A7DC377DEF'></code></optgroup>
        1. <b id='A7DC377DEF'><label id='A7DC377DEF'><select id='A7DC377DEF'><dt id='A7DC377DEF'><span id='A7DC377DEF'></span></dt></select></label></b><u id='A7DC377DEF'></u>
          <i id='A7DC377DEF'><strike id='A7DC377DEF'><tt id='A7DC377DEF'><pre id='A7DC377DEF'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:2
          Amgen HQ
          Mark J. Terrill/AP

          A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

          The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

          advertisement

          Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Bursting ice dam in Alaska highlights risks of glacial flooding around the globe
          Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

          ChrisWinterstandsinherhomeinJuneau,Alaska,onMonday,Aug.7,2023,afteraweekendglaciallakeoutburstfloodr

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

          1:03U.S.Marineswiththe26thMarineExpeditionaryUnitMaritimeSpecialPurposeForce,preparetodeparttheUSSBa